When leaders at Methodist Le Bonheur Healthcare (MLH), a not-for-profit health system based in Memphis, Tenn., saw the opportunity to standardize their suite of diagnostic imaging solutions, they capitalized on it. The seven-hospital system will deploy McKesson’s portfolio of enterprise medical imaging products across its various facilities to help improve physician collaboration, streamline data management and simplify its imaging archive process with a single point of access.

JenaValve Technology, Inc. announced that it has raised $62.5 million in a Series C venture round.

Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to supply its entire portfolio of Food and Drug Administration (FDA)-approved positron emission tomography (PET) radiopharmaceutical agents at each of PETNET Solutions’ current Good Manufacturing Practices (cGMP)-certified locations throughout the United States.

In 1988, the first Transcatheter Cardiovascular Therapeutics conference was held with less than 200 attendees in the basement of the Omni Shoreham Hotel in Washington, DC. The first meeting, a forum where physicians came to exchange ideas and compare emerging technologies, featured a single live case transmitted from Georgetown University School of Medicine.

A new study of patients who died of sudden cardiac arrest, a usually fatal condition that causes the heart to stop beating, shows the majority who qualified to receive potentially lifesaving treatment did not receive it.

Researchers have determined that fingerstick cardiac troponin I assay testing using the point-of-care i-STAT device is not accurate enough to determine the exact troponin level without the application of a corrective term.